Editorial
Published on 19 Sep 2023
Editorial: Antibiotic allergy de-labelling and management
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1278690
- 2,009 views
- 1 citation
Type at least 3 characters
64 articles
articles
Brief Research Report
Published on 31 Jul 2023
Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical center
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1161683
- 5,749 views
- 3 citations
Case Report
Published on 27 Jul 2023
Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1228495
- 4,367 views
- 5 citations
Editorial
Published on 13 Jul 2023
Editorial: Assessment and management of adverse drug reactions in oncology
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1223078
- 2,457 views
- 1 citation
Original Research
Published on 04 Jul 2023
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1126012
- 4,373 views
- 7 citations
Editorial
Published on 24 May 2023
Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1214914
- 2,298 views
Editorial
Published on 11 May 2023
Editorial: Diagnosis and management of allergy to chemotherapy and biologics
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1205345
- 3,589 views
- 7 citations
Case Report
Published on 09 May 2023
Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1089966
- 3,825 views
- 4 citations
Brief Research Report
Published on 03 May 2023
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1056619
- 3,589 views
- 2 citations
Brief Research Report
Published on 30 Mar 2023
A potential cost savings analysis of a penicillin de-labeling program
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1101321
- 3,608 views
- 10 citations
Mini Review
Published on 16 Mar 2023
Delabelling multiple antibiotic allergy: Practical issues
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1156137
- 6,476 views
- 7 citations
Mini Review
Published on 02 Mar 2023
Mucocutaneous adverse events to immune checkpoint inhibitors
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1147513
- 7,177 views
- 12 citations
Original Research
Published on 06 Jan 2023
Cofactors of drug hypersensitivity—A monocenter retrospective analysis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1097977
- 3,260 views
- 2 citations
Brief Research Report
Published on 20 Dec 2022
SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1046545
- 3,964 views
- 2 citations
Original Research
Published on 05 Dec 2022
Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1071807
- 6,058 views
- 22 citations
Original Research
Published on 05 Dec 2022
Drug allergy evaluation in children with suspected mild antibiotic allergy
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1050048
- 3,735 views
- 2 citations
Mini Review
Published on 22 Nov 2022
Differences in beta-lactam and penicillin allergy: Beyond the West and focusing on Asia-Pacific
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.1059321
- 5,949 views
- 26 citations
Original Research
Published on 05 Sep 2022
Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.974138
- 6,107 views
- 18 citations
Brief Research Report
Published on 16 Aug 2022
Prevalence and impact of misdiagnosed drug allergy labels among patients with hereditary angioedema
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.953117
- 3,568 views
- 13 citations
Community Case Study
Published on 29 Jul 2022
Multi-phasic life-threatening anaphylaxis refractory to epinephrine managed by extracorporeal membrane oxygenation (ECMO): A case report
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.934436
- 4,238 views
- 10 citations
Original Research
Published on 13 Jul 2022
Basophil Activation Test as a Biomarker for Taxanes Anaphylaxis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.787749
- 4,606 views
- 6 citations
Community Case Study
Published on 16 Jun 2022
Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.868300
- 3,378 views
- 4 citations
Editorial
Published on 14 Jun 2022
Editorial: Adverse Vaccine Reactions
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.948380
- 1,676 views
Review
Published on 09 Jun 2022
Penicillin Allergy and Perioperative Anaphylaxis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2022.903161
- 11,714 views
- 9 citations